Senate Committee advances bill to create Prescription Drug Affordability Board after lengthy public debate The Senate Insurance Committee reported SB401 as amended on April 1, 2026. Sponsors said the board will gather manufacturer pricing data and recommend whether costs are justified; patient advocates warned the information could later be used to restrict access. A sunset and proprietary-data protections were added.

A new bill in Louisiana aims to create a Prescription Drug Affordability Board to ensure fair pricing, but advocates warn it could jeopardize patient access to essential medications.

Learn more here!

#LA #CitizenPortal #LouisianaPrescriptionDrugs #DrugAffordability #PatientAccess

Committee approves ban on pay‑for‑delay drug deals to preserve generic access Senate Bill S3203, which would ban pay‑for‑delay arrangements that keep generics off the market, was reported to first reading after committee discussion about prevalence and patient impacts; sponsor named as Senator Fernandez.

A new bill aiming to ban pay-for-delay agreements could revolutionize access to affordable medications for millions of patients.

Click to read more!

#NY #CivicAccountability #CitizenPortal #NewYorkPublicHealth #HealthPolicy #DrugAffordability

EACH/PIC Releases Results from Patient-Led Survey on Drug Affordability | EACH/PIC Coalition Patient-Led Survey Reveals Insurance Barriers and Personal Factors Contribute Significantly to Patient Affordability Concerns

What do patients really think about drug costs?
New survey from @eachpic finds affordability is often about access and insurance policies

Learn more: eachpic.org/each-pic-rel...

#DrugAffordability #PatientsFirst

Oregon Prescription Drug Affordability Board June, 18, 2025 Meeting Highlights presented by OCAP

Which Drugs Made the List? 16 prescription drugs and 7 insulin products selected for affordability review 4 orphan drugs (e.g., Humira, Botox) removed due to current statute Selection focused on cost (net payer) and patient volume

What's Powering the Decisions? Data from 11 commercial insurers (net cost) APAC data (gross cost incl. Medicare/Medicaid) New PDAB dashboard features: Drug lookup NDC info Plan designs

Looking Ahead Next PDAB Meeting: July 16, 2025 @ 9 AM Tune in for the start of affordability reviews! Insulin review scheduled for later in 2025 Public hearing on PBM rulemaking: June 23 Board member recruitment extended to July 7

At last week's meeting, the Oregon Prescription Drug Affordability Board (#PDAB) reviewed data, approved a 16-drug review list, and discussed #insulin pricing. Learn more in the slides →

Next meeting: July 16, 2025 at 9 AM.

#OregonPDAB #DrugAffordability #HealthPolicy #InsulinAccess #OCAP

The High Cost of Middlemen Medicine — HIV-HCV Co-Infection Watch For millions of Americans, the promises of modern medicine are starting to sound a lot like a scam. Despite breakthrough treatments and historic R&D investments, every year more and more people can’t…

CANN Blog: Americans spent $98B out-of-pocket on prescriptions in 2024 while drug net prices grew just 0.1%. The culprits? PBMs, insurance barriers & misused #340B programs.
This isn't just an affordability crisis—it's a moral one.
buff.ly/z7VEOoJ #HealthPolicy #DrugAffordability #HealthcareAccess

Pharmacy benefit managers face new audit restrictions under SEA 80 legislation SEA 80 limits fees and conditions for pharmacy benefit manager audits and disclosures.

Indiana's Senate Bill 80 could revolutionize drug pricing by demanding transparency from pharmacy benefit managers, but will it come at a cost to consumers?

Click to read more!

#IN #HealthcareReform #CitizenPortal #DrugAffordability

Maryland investigates drug pricing differences with Germany to address affordability crisis Maryland seeks to establish upper payment limits to combat rising prescription drug costs.

Maryland is taking bold steps to tackle skyrocketing drug prices that force many residents to skip vital medications—could this be the solution we've been waiting for?

Learn more here

#MD #DrugAffordability #CivicAccountability #CitizenPortal #MarylandPrescriptionDrugs #HealthcareReform

850,000 Americans Will Have Cheaper Drug Prescriptions in 2025

850,000 Americans Will Have Cheaper Drug Prescriptions in 2025

Starting in 2025, over 850,000 Americans with Medicare will benefit from lower prescription drug ...

#medicare #prescriptiondrugs #healthcareaccess #inflationreduction #drugaffordability